Part 7/11:
Winters also points out the revolving door between regulators and corporations. Former FDA officials often transition into lucrative roles within big pharma. For example, individuals involved in approving controversial drugs or labels go on to work for pharmaceutical giants like Purdue Pharma. This paradise of job preservation creates a conflict of interest, where regulatory decisions are influenced by financial ties, rather than public health priorities.